Related Experiment Video
Updated: May 25, 2026
05:21
A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection
Published on: August 14, 2019
Influenza vaccination for older adults
H Keipp B Talbot1, Romina Libster, Kathryn M Edwards
1Departments of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA.
Human Vaccines & Immunotherapeutics
|January 19, 2012
Summary
Annual influenza vaccination is recommended for adults 65 and older to prevent hospitalizations and deaths. New vaccines are in development to improve protection for this vulnerable population.
Area of Science:
- Immunology
- Vaccinology
- Geriatric Medicine
Background:
- Influenza poses significant health risks, including morbidity and mortality, particularly for adults aged 65 and older.
- Early influenza vaccine recommendations for older adults were based on efficacy data from younger populations.
- While studies show effectiveness in older adults, it is generally lower than in younger individuals.
Purpose of the Study:
- To review the history and current status of influenza vaccination in older adults.
- To highlight the need for improved influenza vaccine strategies for the elderly.
- To emphasize the ongoing importance of annual vaccination with existing vaccines.
Main Methods:
- Review of historical randomized clinical trials on influenza vaccine efficacy in young adults.
- Analysis of studies evaluating influenza vaccine effectiveness in adults aged 65 and older.
- Discussion of ongoing research and development of new influenza vaccines.
Main Results:
- Influenza vaccines demonstrated efficacy in preventing influenza in young, healthy adults.
- Vaccine effectiveness in older adults is generally lower compared to younger populations.
- Current annual vaccination prevents a substantial number of hospitalizations and deaths in older adults.
Conclusions:
- Despite lower effectiveness, annual influenza vaccination remains crucial for preventing severe outcomes in adults 65 and older.
- Development of new influenza vaccines with enhanced immunogenicity is underway to improve protection for the elderly.
- Continued annual administration of licensed influenza vaccines is essential to mitigate influenza-related morbidity and mortality in this age group.
Related Concept Videos
01:27Influenza
Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
01:51Vaccinations
Overview
01:30Pneumonia V: Nursing management and Prevention
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...